Long acting risperidone


This 53-wk, Phase-III double-blind study was designed to assess the non-inferiority of PP to risperidone long-acting injectable (RIS-LAI) in schizophrenia. Risperidone is a long-acting injection that is used to treat schizophrenia and mental health issues. Learn about risperidone side effects and. Risperidone long acting injection (RLAI) is a long acting injectable preparation of risperidone. Currently it is the only atypical antipsychotic. RISPERDAL. ®. CONSTA. ®. (risperidone) Long-Acting Injection is a combination of extended release microspheres for injection and diluent for parenteral use.

The efficacy and safety of long-acting injectable risperidone have been evaluated in several trials of patients with schizophrenia or schizoaffective disorder. The pharmacokinetics and tolerability of long-acting risperidone (Risperdal Consta™) were evaluated in a multicenter, bula bactrim f suspensão, open-label, 15-week study o.

Original Article from The New England Journal of Medicine — Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia. Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The purpose of this study is to compare the efficacy of oral risperidone (Risperdal) to risperidone long-acting (Consta) in reducing alcohol use in persons.

Formulation. These evidence based guidelines aim to assist clinicians in the appropriate and effective prescribing of Risperidone Long Acting Injection (RLAI).